～Global Innovation Seminar～ Japan’s MedTech Start-Up Frontier（3rd Sep, 2025(Wed.)）

Campus Create is currently offering a hands-on support program to help Japanese startups in the medical and healthcare sectors expand into the Singapore market.

As the kickoff to this program, we have organized an online seminar in collaboration with our Singapore partner, Origgin Ventures Pte Ltd.

In this seminar, we will present a comprehensive overview of Japan’s startup ecosystem and innovation landscape, with a focus on the medical technology sector. Japanese startups and university researchers aiming for global expansion will also showcase their technologies, products, and strategies for entering international markets.

Our goal is to highlight the potential of Japanese medical technology in the Singapore market, strengthen collaboration between Japan and Singapore in the medical and healthcare sectors, and create new business opportunities.

We look forward to your participation.

【Date・Time】
3^rd Sep, 2025(Wed.)   14:00 – 16:30(Japan Time) / 13:00 – 15:30(Singapore Time)

Online seminar via ZOOM, Free to Join
Please register from here
↓↓
https://forms.gle/tNnnpVXpksvEf2Z16

【Seminar Language】 Japanese and English (Simultaneous interpretation)

14:00-14:10(JP)/13:00-13:10(SG)
Opening Remarks (Campus Create Co., Ltd)
Greeting and Introduction from Co-Organizer (Origgin Ventures Pte Ltd. )

14:10-14:25(JP)/13:10-13:25(SG)
Keynote1
University-Based Startup Ecosystem in Japan: A Case Study of Chiba University 
Yoichi ONO, Innovation Management Researcher,
IMO Startup Lab, Chiba University　

14:25-14:40(JP)/13:25-13:40(SG)
Keynote2
BIZEN; A hub for medical innovation to cultivate talents and businesses.
Yoshinari SENGOKU, Senior Research Manager
Medical Device Development Division, Center for New Medical Research and Development, Okayama University Hospital

14:40-15:05(JP)/13:40-14:05 (SG)
Session1
A new healthcare service that estimates cancer risk by assessing DNA damage from just a single drop of blood.
Kenta TAKAHASHI, Founder & CEO, Dinow Inc.

15:05-15:30(JP)/14:05-14:30 (SG)
Session2
StA2BLE – See the Risk, Move to Prevent -A science-based solution to assess and prevent fall risks.
Toya KAMIJO, Manager, Corporate Strategy Planning. UNTRACKED Inc

15:30-15:55(JP)/14:30-14:55(SG)
Session3
Wellness Monitoring via Human Skin Gas Analysis
Yoshika SEKINE, Professor, School of Science, Tokai University

15:55-16:20(JP)/14:55-15:20(SG)
Session4
Non-invasive imaging and quantification of tissue fibrosis -ASEM Technology
Kenji IKUSHIMA, CEO, ASEMtech Inc.

16:20-16:30(JP)/15:20-15:30(SG)
Closing Remarks (Campus Create Co., Ltd)

Keynote Speech 1
Title:University-Based Startup Ecosystem in Japan: A Case Study of Chiba University 
Speaker: Yoichi ONO, Innovation Management Researcher,
IMO Startup Lab, Chiba University

Abstract:This presentation examines Japan’s university-based startup ecosystem through the case of Chiba University. It highlights national policies, support programs,  and industry–academic collaboration that foster innovation. While Japan’s  model emphasizes stability and partnerships, it also faces challenges such as  slower decision-making and limited risk tolerance compared with Western  ecosystems. Chiba University’s initiatives illustrate both the strengths and  areas for growth in creating globally competitive university startups.

Keynote Speech2
Title: BIZEN; A hub for medical innovation to cultivate talents and businesses.
Speaker: Yoshinari SENGOKU, Senior Research Manager
Medical Device Development Division, Center for New Medical Research and Development, Okayama University Hospital

Abstract: BIZEN is a practical program for medical open innovation conducted by Okayama University Hospital. It aims to cultivate talents and businesses by opening the infrastructure of hospitals and universities to explore needs and validate hypotheses in the field. In this presentation, we will introduce the “BIZEN Design Flow,” which analyzes needs and aims for practical application, along with methods for meticulous and reliable verification and commercialization.
Additionally, we will explain the system in which experts provide advice on essential matters for the development of medical devices, including regulatory affairs, insurance coverage, and medical operations.

Session 1
Title: A new healthcare service that estimates cancer risk by assessing DNA damage from just a single drop of blood.
Speaker: Kenta TAKAHASHI Founder & CEO, Dinow Inc.

Abstract: We are a healthcare company that solves the health concerns of radiation workers through a new evaluation method based on DNA damage assessment. In this seminar, we will present our cancer risk assessment approach using DNA damage visualization technology developed through research at Ibaraki University.

Session 2
Title: StA2BLE – See the Risk, Move to Prevent -A science-based solution to assess and prevent fall risks.
Speaker: Toya KAMIJO, Manager, Corporate Strategy Planning UNTRACKED Inc.

Abstract: This presentation will introduce StA²BLE, a measurement device that visualizes fall risk in just one minute and recommends individually optimized exercises. In addition to applications in the healthcare field aimed at supporting the independence of older adults and reducing caregiving burdens, it also contributes to worker safety management in the manufacturing industry and to strengthening community-based integrated care by local governments.
We will discuss the development of a science-based fall prevention support model and its potential applications across diverse sectors.

Session 3
Title: Wellness Monitoring via Human Skin Gas Analysis
Speaker: Yoshika SEKINE, Professor, School of Science, Tokai University

Abstract: Human body odor consists of various volatile compounds emitted from the skin surface, collectively referred to as human skin gas. Skin gas is a biological signal that can be continuously and autonomously obtained from the body surface, offering promising potential for cross-disciplinary industrial applications. This presentation will highlight recent academic advances in skin gas research and showcase development initiatives aimed at promoting wellness through innovative monitoring technologies.

Session 4
Title: Non-invasive imaging and quantification of tissue fibrosis — ASEM Technology
Speaker: Kenji IKUSHIMA, CEO, ASEMtech Inc.

Abstract: ASEM Technology is an innovative measurement platform for non-invasive visualization and quantification of tissue fibrosis. We have discovered that fibrotic tissue exhibits piezoelectric properties, generating high-frequency electrical signals when stimulated by ultrasound. By imaging this acoustically stimulated electromagnetic response—termed the ASEM response—we can visualize fibrotic and degenerative changes in musculoskeletal and organ tissues.
By transforming the conventional biopsy-dependent and delayed evaluation process into a rapid, non-invasive diagnostic workflow, ASEM empowers healthcare professionals with actionable insights while enhancing patient safety and comfort.